Skip to main content
Fig. 5 | World Journal of Surgical Oncology

Fig. 5

From: HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis

Fig. 5

HSDL2 knockdown suppresses ferroptosis by inhibiting the P53-SLC7A11 pathway. A, B The SLC7A11 expression in the indicated cells were evaluated using western blotting. C-H The relative reactive oxygen species (ROS) (C, D), malonaldehyde (MDA) (E, F), and glutathione (GSH) (G, H) levels in the indicated groups were measured using the corresponding kits. Data are presented as mean ± SD (n=3). *p < 0.05,**p < 0.01, and ***p < 0.001

Back to article page